FAQ

Inflammatory Breast Carcinoma

Known as: Inflammatory Breast Cancer, Neoplasms, Inflammatory Breast, breast inflammatory cancer 
An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1951-2018
02040608019512017

Related topics

Related topics

20 relations
AdenocarcinomaBlood supply aspectsBreastEdema
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Inflammatory Breast Carcinoma
Pain
cancer cell
Edema
Adenocarcinoma
radiotherapeutic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label…
BACKGROUND Studies with pertuzumab, a novel anti-HER2 antibody, show improved efficacy when combined with the established HER2… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
PURPOSE To examine the role of cancer stem cells (CSC) in mediating metastasis in inflammatory breast cancer (IBC) and the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a…
BACKGROUND The monoclonal antibody trastuzumab has survival benefit when given with chemotherapy to patients with early, operable… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
A stromal gene signature associated with inflammatory breast cancer.
The factors that determine whether a breast carcinoma will develop into inflammatory breast cancer (IBC) remain poorly understood… (More)
  • table I
  • figure 1
  • table II
  • table III
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
BACKGROUND Inflammatory breast carcinoma (IBC) appears to be a clinicopathologic entity distinct from noninflammatory locally… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
PURPOSE At the time of diagnosis, metastatic dissemination of tumor cells via the lymphatic system has occurred in nearly all… (More)
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients…
PURPOSE This study (EGF10004) assessed the safety/tolerability, pharmacokinetics, and clinical activity of daily oral dosing with… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Persistent E-Cadherin Expression in Inflammatory Breast Cancer
E-cadherin is a transmembrane glycoprotein that mediates epithelial cell-to-cell adhesion. Because loss of E-cadherin expression… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer and is phenotypically distinct from other forms of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Twenty-seven cases of inflammatory breast cancer were screened for the presence of the p53 protein by immunocytochemical methods… (More)
Is this relevant?